Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 85 for “"Dyslipidemia"”.
-
Nutritional Factors and Dyslipidemia according to Diabetes Mellitus
"- 국문요약 - 당뇨병 유무에 따른 영양학적 요인과 이상지질혈증과의 관련성 최근의 5대 주요사망원인은 암, 뇌혈관질환, 심장질환, 고의적 자해(자살), 당뇨병이며, 뇌혈관질환의 중요한 위험요인으로 고지혈증 있다. 이상지혈증은 당뇨병과 자주 동반될 뿐아니라, 당뇨병 그 자체가 대혈관 질환의 주요 위험인자로 지적되고 있는 것이다. 또한 이상지질혈증은 영양학적요인과 깊은 관련이 있는 것으로 알려져 있다. 따라서, 전체인구집단을 대상으로 심혈관질환의 주요 위험요인인 이상지질혈증(HDL-C, LDL-C, TC, TG)의 유병율을 알아보고 …
-
The Evaluation of Chinese therapeutic food for the treatment of dyslipidemia
… favorable effects of both on the treatment of dyslipidemia and atherosclerosis. This clinical study suggests that the intake of hawthorn fruit and Chinese kiwifruit supplement may increase the serum levels of HDL-c and decrease the ratios of TC/HDL-c and LDL-c/HDL-c, and therefore may reduce …
-
Association Between Obesity and Therapeutic Goal Attianment in Patients with Concomitant Hypertension and Dyslipidemia
… in patients with concomitant hypertension and dyslipidemia, specifically comparing obese versus non-obese patients. Methods: GE Centricity EMR database containing data from 2004-2011 was utilized. 9,086 patients diagnosed with concomitant hypertension and dyslipidemia were evaluated. Goal …
-
Mapping Genes for Complex Traits: Obesity, Diabetes, Hypertension, and Dyslipidemia on the Pacific Island of Kosrae
… X: obesity, type II diabetes, hypertension, and dyslipidemia. This resulted in a number of additional suggestions, such as phenotypic and genotypic corrections, dealing with mixing issues, and inspection of L-graphs for signal reliability. Once this strategy was developed, the second part of this …
-
Independent and interacting effects of diet and genetic risk on obesity-related comorbidities
Introduction: Dyslipidemia results from behavioral and biological factors. Elevated triglyceride (TG) and decreased high-density lipoprotein cholesterol (HDL-C) concentrations are common in obesity. Dietary guidelines for dyslipidemia management encourage replacing saturated (SFA) with unsaturated …
-
Cardiometabolic Diseases and HIV Infection: The Impact of Highly Active Antiretroviral Therapy
… To determine the incidence rate of diabetes, dyslipidemia, and cardiovascular (CVD) events in a retrospective cohort of HIV-infected and non-HIV-infected individuals. And to evaluate the association of these outcomes with exposure to highly active antiretroviral therapy (HAART) medications …
-
Investigating the Role of Standing Blood Pressure Measurement and the Association Between High-Density Lipoprotein and Skeletal Muscle Mitochondrial Function in Pre-Hypertensive Humans
… CVD is the presence of hypertension (HTN) and dyslipidemia. Despite this, there are critical knowledge gaps related to 1) obtaining an accurate clinical assessment of blood pressure (BP), and 2) the mechanisms by which dyslipidemia evoke enhanced cardiometabolic disease risk. Specifically, this …
-
The UP AMIGOS project: Testing the predictive validity of the 2007 Pediatric Expert Committee Recommendations in Latinos
… non-alcoholic fatty liver disease (NAFLD), (2) dyslipidemia, and (2) impaired fasting glucose. The second aim was to test the sensitivity and specificity of the Pediatric Expert Committee Recommendations (PECR) in identifying Mexicans with these three cardiovascular disease risk factors. …
-
Pattern and distribution of peripheral arterial disease in diabetic patients with critical limb ischemia (Rutherford Clinical Category 4-6)
… risk factor combinations [ Group1 = (DM, HPT, Dyslipidemia); Group 2= (DM, HPT, dyslipidemia, exsmoker); Group 3 = (DM, HPT, dyslipidemia, smoker)]. The three risk combination groups formed the majority of our study group (79%).
-
Sleep and Cardiometabolic Health in Adults: Contributions of Lifestyle and Dietary Factors, Objective vs. Subjective Sleep, and Change in Sleep Habits
… the risk of developing hypertension, diabetes, dyslipidemia and obesity due to changes in objectively measured sleep duration and efficiency in a 4 y follow-up. The US National Health and Nutritional Examination Survey and the Sleep Heart Health Study data were used. Mediation analyses, Pearsons …
-
Novel Roles of GLP-1 and GLP-2 in the Regulation of Hepatic Lipid/Lipoprotein Homeostasis and the Involvement of BAT Activation
… agonist exendin-4 decreased body weight, fasting dyslipidemia and VLDL overproduction by enhancing lipid utilization and decreasing hepatic de novo lipogenesis. These effects occurred through a vagal signalling pathway and were independent of changes in food consumption. To assess the involvement …
-
Interaction between dietary factors and genetic risk for lipoprotein traits and cardiovascular disease
… examined whether an overall genetic risk for dyslipidemia can be modified by diet quality and whether diet quality can increase the risk of dyslipidemia and CVD. We used the population-based Malmö Diet and Cancer study (n=28,098, 61% women) that included baseline examinations that were …
-
Inflammatory mediators in diabetic retinopathy
… were studied in early diabetes in mice. Dyslipidemia and the anti-inflammatory effects of lipid-modulating compounds as well as an immunoregulating role of TNF-α were also analyzed. These studies support that inflammation, which might be aggravated by dyslipidemia, has a role in early as …
-
Discovery of botanical flavonoids as dual peroxisome proliforator, activated receptor (PPAR) ligands and functional characterization of a natural PPAR polymorphism that enhances interaction with nuclear compressor
… in the management of the epidemic of diabetes, dyslipidemia and the metabolic syndrome.
-
The epidemiology of clustered risk factors compatible with Metabolic Syndrome in Hawai‘i
… glucose intolerance, abdominal obesity, dyslipidemia and elevated blood pressure. Over the past two decades the world has experienced a sharp increase in the number of people with MetS. It is estimated that around 20--25 percent of the world's adult population now have metabolic syndrome. …
-
Motivational Interviewing as a Lifestyle Management Strategy for Dyslipidemic Overweight and Obese Adolescents
Background: Dyslipidemia, overweight and obesity (OW/OB) in the pediatric population contributes to metabolic complications and future cardiovascular disease. The prevalence varies but the problem is a global issue. Adolescence is a challenging developmental stage with many factors influencing …
-
HIV Protease Inhibitors Trigger Lipid Metabolism Dysregulation Through Endoplasmic Reticulum Stress and Autophagy
… load, but have been linked to lipodystrophy and dyslipidemia, which are major risk factors for cardiovascular disease. Recent studies indicate that activation of endoplasmic reticulum (ER) stress is an important cellular mechanism underlying HIV PI-induced dysregulation of lipid metabolism. …
-
Proteolethargy is a pathogenic mechanism in chronic disease
… pathogenic stimuli, including hyperglycemia, dyslipidemia, and inflammation, produce similar reduced protein mobility phenotypes. I propose that proteolethargy is an overlooked cellular mechanism that may account for various pathogenic features of diverse chronic diseases.
-
Molecular Mechanisms Governing the Pharmacology of LDT409 for the Treatment of Metabolic Disease
… of metabolic diseases, including obesity, dyslipidemia, and type 2 diabetes, is dramatically increasing in the world; thus, it is important to develop effective, low cost, and safe medications to treat these diseases. The peroxisome proliferator-activated receptors (PPARa/g/b) are fatty …
-
Predicting Obstructive Coronary Artery Disease in Patients Undergoing Coronary Angiography for Stable Angina
… relievers), and co-morbidities (hypertension, dyslipidemia, diabetes, smoking, family history, cerebrovascular disease, peripheral vascular disease) to predict the presence of obstructive CAD. Prior to model development, multiple imputation methods were used to generate 25 randomly imputed …
Page 1 of 5